Loading...
Symbols:
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
Transcripts
- National Semiconductor Corporation F1Q09 (Qtr End 08/24/08) Earnings Call Transcript
- Aceto Corporation F4Q08 (Qtr End 06/30/08) Earnings Call Transcript
- Logility, Inc. F1Q09 (Qtr End 07/31/08) Earnings Call Transcript
- Smith Micro Software, Inc. Q2 2008 Earnings Call Transcript
- BioForm Medical, Inc. F4Q08 (Qtr End 06/30/08) Earnings Call Transcript
- Sycamore Networks, Inc. F4Q08 (Qtr End 07/31/08) Earnings Call Transcript
- Alliance Imaging, Inc. Q2 2008 Earnings Call Transcript
- Somaxon Pharmaceuticals, Inc. Q2 2008 Earnings Call Transcript
- Volcano Corporation Q2 2008 Earnings Call Transcript
- ABM Industries Incorporated F3Q08 (Qtr End 07/31/08) Earnings Call Transcript
-
Editor's Picks
-
Most Popular
- Welcome to the Mortgage Business
- GSEs Into Conservatorship: Can Housing Stabilize Now?
- Buying Berkshire: The Ultimate No-Brainer
- PowerShares Dynamic Retail ETF Finds Bargains in Discount Retailers
- Global Stock Markets: We All Fall Down!
- American Capital Agency: Making Money the Old-Fashioned Way
- Full list of Editor's Picks »
- Wall Street Breakfast: Must-Know News »
- Apple: Steve and I Have Been Wrong »
- What Will Fannie / Freddie Mean for Monday? »
- Gold Futures' Dirty Secret (Part II) »
- A First Look Inside the Fannie / Freddie Bailout Plan »
- Rescuing Frannie »
- Why Commodities May Be Nearing a Turning Point »
- Bill Ackman's Letter to Paulson On Restructuring Plan »
- Is Gold Getting Ready to Bounce? »
- Corning: Looking Very Cheap »
- Friday Outlook: What Phony Sell-off?! »
Trading Center
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
in my DNA
1 Comment
Genentech's Avastin: An Undeserving Target for Politicians and the Media [view article]
Someone asked why not $55k per year instead of $100k+ per year. It costs Genentech between $500M and $800M to get a drug approved. Genentech then only has a limited time as patent owner before the generics can move in to make their versions. Genentech must also fund future research so they have new products. Genentech is a growth stock, not a dividend stock, and applies profits to further research.One more thing to consider. Genentech offers assistance to patients that can not afford a Genentech product. Please check out the genentechaccessolution... website for more details.
Disclosure- Yes, I am a member of the Genentech Team and proud of it. Apr 03 01:14 AM